Titre : Syndrome de Noonan

Syndrome de Noonan : Questions médicales fréquentes

Termes MeSH sélectionnés :

Diagnostic and Statistical Manual of Mental Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome de Noonan : Questions médicales les plus fréquentes", "headline": "Syndrome de Noonan : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome de Noonan : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-09", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome de Noonan" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies du tissu conjonctif", "url": "https://questionsmedicales.fr/mesh/D003240", "about": { "@type": "MedicalCondition", "name": "Maladies du tissu conjonctif", "code": { "@type": "MedicalCode", "code": "D003240", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C17.300" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome de Noonan", "alternateName": "Noonan Syndrome", "code": { "@type": "MedicalCode", "code": "D009634", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marco Tartaglia", "url": "https://questionsmedicales.fr/author/Marco%20Tartaglia", "affiliation": { "@type": "Organization", "name": "Genetics and Rare Diseases Research Division, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy." } }, { "@type": "Person", "name": "Yoko Aoki", "url": "https://questionsmedicales.fr/author/Yoko%20Aoki", "affiliation": { "@type": "Organization", "name": "Department of Medical Genetics, Tohoku University School of Medicine, Sendai, Japan." } }, { "@type": "Person", "name": "Thomas Edouard", "url": "https://questionsmedicales.fr/author/Thomas%20Edouard", "affiliation": { "@type": "Organization", "name": "Endocrine, Bone Diseases, and Genetics Unit, Children's Hospital, Toulouse University Hospital, 330, avenue de Grande-Bretagne TSA 70034, 31059 Toulouse Cedex 9, France. Electronic address: edouard.t@chu-toulouse.fr." } }, { "@type": "Person", "name": "Paolo Alfieri", "url": "https://questionsmedicales.fr/author/Paolo%20Alfieri", "affiliation": { "@type": "Organization", "name": "Child and Adolescent Psychiatric Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy." } }, { "@type": "Person", "name": "Martin Zenker", "url": "https://questionsmedicales.fr/author/Martin%20Zenker", "affiliation": { "@type": "Organization", "name": "Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany martin.zenker@med.ovgu.de." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries.", "datePublished": "2023-07-30", "url": "https://questionsmedicales.fr/article/37531964", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2215-0366(23)00193-1" } }, { "@type": "ScholarlyArticle", "name": "Meta-Analysis of Internet Gaming Disorder Prevalence: Assessing the Impacts of DSM-5 and ICD-11 Diagnostic Criteria.", "datePublished": "2024-05-29", "url": "https://questionsmedicales.fr/article/38928946", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21060700" } }, { "@type": "ScholarlyArticle", "name": "Further validation of the Personality Disorder Severity for ICD-11 (PDS-ICD-11) scale in a community mental health sample.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37384513", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/pas0001253" } }, { "@type": "ScholarlyArticle", "name": "Societal costs of personality disorders: A cross-sectional multicenter study of treatment-seeking patients in mental health services in Norway.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36916214", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jclp.23504" } }, { "@type": "ScholarlyArticle", "name": "The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia.", "datePublished": "2023-04-10", "url": "https://questionsmedicales.fr/article/37038149", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-023-04738-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de la peau et du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D017437" }, { "@type": "ListItem", "position": 3, "name": "Maladies du tissu conjonctif", "item": "https://questionsmedicales.fr/mesh/D003240" }, { "@type": "ListItem", "position": 4, "name": "Syndrome de Noonan", "item": "https://questionsmedicales.fr/mesh/D009634" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome de Noonan - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome de Noonan", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome de Noonan", "description": "Comment diagnostique-t-on le syndrome de Noonan ?\nQuels tests génétiques sont utilisés ?\nQuels signes cliniques aident au diagnostic ?\nLe syndrome de Noonan est-il héréditaire ?\nQuel rôle joue l'échographie prénatale ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome de Noonan", "description": "Quels sont les symptômes principaux du syndrome de Noonan ?\nY a-t-il des problèmes de développement associés ?\nLe syndrome de Noonan affecte-t-il la croissance ?\nQuels traits faciaux sont typiques ?\nY a-t-il des problèmes de vision associés ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome de Noonan", "description": "Peut-on prévenir le syndrome de Noonan ?\nLe dépistage prénatal est-il possible ?\nQuels conseils pour les parents à risque ?\nY a-t-il des tests recommandés pour les familles ?\nComment le soutien psychologique aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome de Noonan", "description": "Quels traitements sont disponibles pour le syndrome de Noonan ?\nLa thérapie physique est-elle recommandée ?\nDes médicaments sont-ils utilisés ?\nComment gérer les problèmes cardiaques ?\nLe suivi médical est-il important ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome de Noonan", "description": "Quelles complications peuvent survenir ?\nLe syndrome de Noonan augmente-t-il le risque de cancer ?\nY a-t-il des problèmes endocriniens associés ?\nLes problèmes cardiaques sont-ils fréquents ?\nComment les complications sont-elles gérées ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome de Noonan", "description": "Quels sont les facteurs de risque du syndrome de Noonan ?\nLe sexe influence-t-il le syndrome de Noonan ?\nLes parents âgés ont-ils un risque accru ?\nY a-t-il des facteurs environnementaux impliqués ?\nLes antécédents médicaux familiaux sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D009634?mesh_terms=Diagnostic+and+Statistical+Manual+of+Mental+Disorders&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le syndrome de Noonan ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen clinique et des tests génétiques pour identifier des mutations." } }, { "@type": "Question", "name": "Quels tests génétiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de séquençage de l'ADN ciblent les gènes associés au syndrome de Noonan." } }, { "@type": "Question", "name": "Quels signes cliniques aident au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des traits faciaux distinctifs, des anomalies cardiaques et des retards de croissance." } }, { "@type": "Question", "name": "Le syndrome de Noonan est-il héréditaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est souvent héréditaire, transmis par un parent porteur d'une mutation génétique." } }, { "@type": "Question", "name": "Quel rôle joue l'échographie prénatale ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie peut détecter certaines anomalies physiques associées au syndrome de Noonan." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux du syndrome de Noonan ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des malformations cardiaques, des traits faciaux particuliers et des retards de croissance." } }, { "@type": "Question", "name": "Y a-t-il des problèmes de développement associés ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des retards de développement et des difficultés d'apprentissage peuvent survenir." } }, { "@type": "Question", "name": "Le syndrome de Noonan affecte-t-il la croissance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent avoir une croissance inférieure à la moyenne et des problèmes de taille." } }, { "@type": "Question", "name": "Quels traits faciaux sont typiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Traits faciaux incluent un front large, des yeux écartés et un cou court." } }, { "@type": "Question", "name": "Y a-t-il des problèmes de vision associés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes oculaires comme le strabisme peuvent être présents chez certains patients." } }, { "@type": "Question", "name": "Peut-on prévenir le syndrome de Noonan ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention, mais un conseil génétique peut aider les familles à risque." } }, { "@type": "Question", "name": "Le dépistage prénatal est-il possible ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage prénatal peut identifier des anomalies, mais pas spécifiquement le syndrome de Noonan." } }, { "@type": "Question", "name": "Quels conseils pour les parents à risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les parents devraient consulter un généticien pour évaluer les risques et les options de dépistage." } }, { "@type": "Question", "name": "Y a-t-il des tests recommandés pour les familles ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques peuvent être recommandés pour les membres de la famille d'un patient atteint." } }, { "@type": "Question", "name": "Comment le soutien psychologique aide-t-il ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le soutien psychologique peut aider les familles à faire face aux défis émotionnels du syndrome." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le syndrome de Noonan ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique et peut inclure des interventions chirurgicales pour les malformations cardiaques." } }, { "@type": "Question", "name": "La thérapie physique est-elle recommandée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie physique peut aider à améliorer la force et la coordination chez les enfants." } }, { "@type": "Question", "name": "Des médicaments sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour traiter des symptômes spécifiques comme l'hypertension." } }, { "@type": "Question", "name": "Comment gérer les problèmes cardiaques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les problèmes cardiaques peuvent nécessiter une surveillance régulière et parfois une chirurgie." } }, { "@type": "Question", "name": "Le suivi médical est-il important ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est crucial pour surveiller la croissance et les complications associées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes cardiaques, des troubles de la coagulation et des retards de développement." } }, { "@type": "Question", "name": "Le syndrome de Noonan augmente-t-il le risque de cancer ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent avoir un risque accru de développer des cancers spécifiques." } }, { "@type": "Question", "name": "Y a-t-il des problèmes endocriniens associés ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles endocriniens comme l'hypothyroïdie peuvent être observés chez certains patients." } }, { "@type": "Question", "name": "Les problèmes cardiaques sont-ils fréquents ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, environ 80% des patients présentent des malformations cardiaques nécessitant une attention." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont gérées par un suivi médical régulier et des traitements adaptés aux symptômes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du syndrome de Noonan ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux de syndrome et des mutations génétiques spécifiques." } }, { "@type": "Question", "name": "Le sexe influence-t-il le syndrome de Noonan ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le syndrome affecte les deux sexes, mais certaines manifestations peuvent varier entre les sexes." } }, { "@type": "Question", "name": "Les parents âgés ont-ils un risque accru ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge avancé des parents peut augmenter le risque de mutations génétiques liées au syndrome." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux impliqués ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves solides liant des facteurs environnementaux au syndrome." } }, { "@type": "Question", "name": "Les antécédents médicaux familiaux sont-ils importants ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de malformations congénitales ou de troubles génétiques peuvent être significatifs." } } ] } ] }

Sources (10000 au total)

Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries.

Information on the frequency and timing of mental disorder onsets across the lifespan is of fundamental importance for public health planning. Broad, cross-national estimates of this information from ... In this cross-national analysis, we analysed data from respondents aged 18 years or older to the World Mental Health surveys, a coordinated series of cross-sectional, face-to-face community epidemiolo... We included 156 331 respondents from 32 surveys in 29 countries, including 12 low-income and middle-income countries and 17 high-income countries, and including 85 308 (54·5%) female respondents and 7... By age 75 years, approximately half the population can expect to develop one or more of the 13 mental disorders considered in this Article. These disorders typically first emerge in childhood, adolesc... None....

Meta-Analysis of Internet Gaming Disorder Prevalence: Assessing the Impacts of DSM-5 and ICD-11 Diagnostic Criteria.

With the inclusion of Internet gaming disorder (IGD) in both the DSM-5 and ICD-11, understanding the prevalence and diagnostic discrepancies is crucial for developing appropriate interventions. This s...

Societal costs of personality disorders: A cross-sectional multicenter study of treatment-seeking patients in mental health services in Norway.

There is a relatively small body of research on the cost-of-illness of personality disorders (PDs). Most studies only include borderline PD. The aim of this study was to investigate mean societal cost... Cross-sectional data from 911 patients diagnosed with at least 1 PD were retrieved from the quality register of the Norwegian Network for Personality Disorders-a collaboration of PD treatment units wi... The mean societal costs were €20.260 during the 6-month period before specialized treatment. The largest cost component was productivity loss (65%), whereas health service costs constituted 35%. The m... Societal costs were substantial among treatment-seeking patients with the broad range of DSM-5 PDs, comparable to the societal costs of schizophrenia, and significantly higher than the societal costs ...

The co-morbidity of DSM-V Gambling with DSM-V mental disorders and substance abuse in a Kenyan context of high risk schizophrenia.

There is evidence that gambling disorder shares similarities with other types of addictive behavior, such as occurs in substance abuse. In addition, co-morbidity of gambling with mental disorders has ... This study aimed at determining the comorbidity of DSM-V gambling disorder with DSM-V mental disorders and substance abuse in high school, college and university students in Kenya.... This was a cross-sectional study among 536 high school, college and university students. We collected data on socio-demographic characteristics, economic indicators, DSM-V diagnosis including DSM-V ga... A total of 536 students participated in the study, of which 11.4% (61 out of 536) had DSM-V gambling disorder. Male gender (AOR = 12.0, 95% CI: 4.99-34.3), antisocial personality disorder (AOR = 3.42,... Gambling is highly prevalent in Kenya learning institutions at 11.4% and is associated with mental disorders and substance use. There is a need for public awareness of gambling among Kenyan youths....

Proposal for increasing diagnostic clarity in research and clinical practice by renaming and reframing atypical anorexia nervosa as "Restrictive Eating Disorder" (RED).

Atypical anorexia nervosa (AAN) in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), is characterized by meeting all criteria for anorexia nervosa (AN) except for weight ...

Differences in the Prevalence and Profile of DSM-IV and DSM-5 Alcohol Use Disorders-Results from the Singapore Mental Health Study 2016.

The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria for alcohol use disorders (AUD) was a significant shift from the historical DSM-IV Text Revised version. Followi... Respondents were assessed for lifetime mental disorders using the Composite International Diagnostic Interview (CIDI) administered through face-to-face interviews. Lifetime DSM-IV AUD diagnoses were c... The lifetime prevalence of DSM-IV AUD was 4.6% (0.5% for dependence and 4.1% for abuse) in the adult population, while the lifetime prevalence of DSM-5 AUD was 2.2%. Younger age, male gender, and lowe... While using the DSM-5 criteria would result in a lower prevalence of AUD in Singapore, it remains a highly comorbid condition associated with a poor health-related quality of life that is largely untr...

Caring for adolescents and young adults with attention-deficit/hyperactivity disorder in primary care: seizing opportunities to address youth mental health needs.

To provide primary care providers (PCPs) with updated practical guidance around the assessment and management of attention-deficit/hyperactivity disorder (ADHD) in adolescents and young adults (AYA).... Of the three different presentations of ADHD delineated in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), the Predominantly Inattentive presentation is the most comm... AYA with ADHD often seek care first from PCPs. However, diagnosis and management of ADHD among AYA are challenging, and many clinicians feel ill-equipped, creating concern that many youth may go undia...